Technological developments and innovation remain a key focus area amid the pandemic as efficient health care equipments are the preference. In 2021, investments are being done by manufacturers on research and development for maintaining their position in the esophagel obturator airway kit market.
Zoll Medical in 2020 entered into an agreement with CAIRE Inc. for the distribution of SAROS 4000 Oxygen System specifically designed for military use in US. The system is a military grade portable oxygen concentrator and can consistently maintain FiO2 by adjusting the patient’s respiratory rate and delivering up to 3LPM of oxygen therapy to user.
Further, Sarnova, a leading national specialty distributor of healthcare products and services in July 2020 announced the combination of Digitech and R1 RCM Inc in Partnership with Pamlico Capital and Digitech Founder to create a revenue cycle management solutions for emergency medical services professionals. This collaboration is expected to strengthen the company’s revenue and help patients with their developments.
In June 2020, FICCI announced the launch of Virtual Health care and Hygiene Expo 2020. It was India’s first virtual exhibition and conference organised by FICCI for 22nd to 26th June 2020. The exhibition discussed issues and opportunities in various sectors post covid scenario.
On January 2021, Zoll Medical Corporation, an Asahi Kasei Company announced its launch of ZOLL AED 3 BLS automated external defibrillators which are awarded with 5 star ratings by World of Safety & Health Asia in its inaugural Innovative solutions Program. These external defibrillators are developed as smart technology to act quickly in medical emergencies.
According to Future Health Index (FHI) 2019, India is the expected leader of digital health technologies with 76% health care professionals already using digital heath records.
The esophageal obturator airway kit is generally used in the management of cardiopulmonary arrest that obstructs the esophagus while simultaneously ventilating the lungs. Over the past two decades, the esophageal obturator airway kit is safely used in around 4 million patients and is considered to be an effective device during gastrointestinal inflation and cardiopulmonary resuscitation. Previous researches have indicated that insertion of esophageal obturator airway kit was more rapid, accurate, and even requires less training of the paramedical personnel. Growing prevalence of stress and lifestyle-related diseases has been a major cause of heart attack which in turn increases the demand for immediate and effective treatment.
With increasing government investments in healthcare industry and rising demand for novel medical devices, the esophageal obturator airway kit market is likely to witness significant growth in the coming years. Implementation of advanced technologies is a major trend prevailing in the development of medical devices which is likely to create lucrative opportunities for manufactures. However, unawareness about such devices in various regions may confine the progress.
The esophageal obturator airway kit has been considered a beneficial ventilatory technique for use in non-surgical airway ventilation in emergency situations. The esophageal obturator airway kit includes mask, syringe and airway tube with a check valve.
The esophageal obturator airway kit is embedded into the throat and isolates the stomach from the airways by an occlusive balloon situated beneath the tracheal bifurcation. Its purpose to prevent gastrointestinal inflation and regurgitation and to provide ventilation. As ideal endoscopic facilities are frequently inaccessible at the site of ventilation emergency, the use of the esophageal obturator airway kits by trained personnel as an alternative or preceding technique is preferred. Most emergency service agencies have replaced his device by more-advanced airway devices.
The major application of esophageal obturator airway kit includes cardiac arrest, respiratory-related conditions. Esophageal obturator airway kit was restricted for use in cardiac applications and was used to guide the placement of pacing lead tip in the heart. Esophageal obturator airway kit are now replacing traditional technology of X-ray fluoroscopy, as it does not clearly visualize soft tissue and also have risks of exposure to ionizing radiations.
The first echogenic catheter was launched in 2008 by MedSystems, which was acquired by St. Jude Medical later in the same year. The global market for esophageal obturator airway kit has seen many changes in technology since then.
Drivers and Restraints
Primary factors driving the market includes growing need for safe and effective devices during cardiopulmonary resuscitation, gastrointestinal inflation. Regurgitation and safety of the technique compared to other alternatives. Besides, need for portable resuscitation devices to overcome risk associated with prehospital cardiac arrest is attributed to growth in demand for Esophageal Obturator Airway Kit across the world over the forecast period.
Esophageal obturator airway kit to replace endotracheal intubation in airway management is another factor driving the growth. Increasing incidence of cardiovascular diseases or stress and lifestyle associated disease is leading cause of cardiac arrest and gastrointestinal inflation and thus demands the increased use of esophageal obturator airway kit over the forecast period. However, lack of awareness regarding the esophageal obturator airway kit and lack of government initiatives program in some developing countries is the factor hampering the growth of the global market.
Based on Product type:
- Air Syringe
- Universal Snap-lock Fitting
- Inflation Indicator
Based on distribution channel:
- Retail Pharmacies
The global market is highly fragmented with local player holding significant share during the forecast period. Manufacturers are indulged in continuous development of esophageal obturator airway kit components such as tubes, masks, and others. Promising revenue growth considered is expected during the forecasted period.
Regional Wise Outlook
Geographically, the global market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to be the leader globally owing to the concentration of key players in the region.
In addition, increasing adaptation of esophageal obturator airway kit in pre-hospital resuscitation procedure is expected to result in higher demand globally over the forecast period. Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by key players. Europe is expected to take second largest share throughout the forecast period.
Some of the key players are Innovaems, Common Cents EMS, Tri-anim Health Services, Brunswick Biomedical Technologies and others. Technological advancement in already marketed products is the major trend emerging in the global esophageal obturator airway kit sector.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent trends, macro-economic indicators and governing factors along with attractiveness as per segments. The report also maps the qualitative impact of various factors on market segments and geographies.
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.